Drugs / Autologous Muscle-derived Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01353690 | Feb 2011 → Dec 2012 | myocardial ischemia | Cook MyoSite | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous Muscle-derived Cells | “Autologous Muscle-derived Cells (AMDC; a preparation of a patient's own cells)” NCT01353690 ↗ |
| Known as | AMDC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01353690 ↗ |
| Modality | Cell therapy | “Autologous Muscle-derived Cell (AMDC) Transplantation” NCT01353690 ↗ |